146 related articles for article (PubMed ID: 36500603)
21. [Study on effect of naringenin in inhibiting migration and invasion of breast cancer cells and its molecular mechanism].
Sun Y; Gu J
Zhongguo Zhong Yao Za Zhi; 2015 Mar; 40(6):1144-50. PubMed ID: 26226761
[TBL] [Abstract][Full Text] [Related]
22. Crocetin inhibits invasiveness of MDA-MB-231 breast cancer cells via downregulation of matrix metalloproteinases.
Chryssanthi DG; Dedes PG; Karamanos NK; Cordopatis P; Lamari FN
Planta Med; 2011 Jan; 77(2):146-51. PubMed ID: 20803418
[TBL] [Abstract][Full Text] [Related]
23. Anacardic acid inhibits the catalytic activity of matrix metalloproteinase-2 and matrix metalloproteinase-9.
Omanakuttan A; Nambiar J; Harris RM; Bose C; Pandurangan N; Varghese RK; Kumar GB; Tainer JA; Banerji A; Perry JJ; Nair BG
Mol Pharmacol; 2012 Oct; 82(4):614-22. PubMed ID: 22745359
[TBL] [Abstract][Full Text] [Related]
24. Methanol extract of Codium fragile inhibits tumor necrosis factor-α-induced matrix metalloproteinase-9 and invasiveness of MDA-MB-231 cells by suppressing nuclear factor-κB activation.
Dilshara MG; Jayasooriya RG; Kang CH; Choi YH; Kim GY
Asian Pac J Trop Med; 2016 Jun; 9(6):535-41. PubMed ID: 27262063
[TBL] [Abstract][Full Text] [Related]
25. Enzymatic inhibitory activity of iridoid glycosides from Picrorrhiza kurroa against matrix metalloproteinases: Correlating in vitro targeted screening and docking.
Rathee D; Lather V; Grewal AS; Dureja H
Comput Biol Chem; 2019 Feb; 78():28-36. PubMed ID: 30497018
[TBL] [Abstract][Full Text] [Related]
26. [Effects of high glucose on in vitro invasiveness of human breast cancer cell line MDA-MB-435].
Li JT; Zhang HW; Guo XH; Sun XF; He YN; Liu CJ; Cui SD; Liu H
Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(2):89-92. PubMed ID: 23648341
[TBL] [Abstract][Full Text] [Related]
27. Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential.
Figueira RC; Gomes LR; Neto JS; Silva FC; Silva ID; Sogayar MC
BMC Cancer; 2009 Jan; 9():20. PubMed ID: 19144199
[TBL] [Abstract][Full Text] [Related]
28. Differential expression of matrix metalloproteinases in brain- and bone-seeking clones of metastatic MDA-MB-231 breast cancer cells.
Stark AM; Anuszkiewicz B; Mentlein R; Yoneda T; Mehdorn HM; Held-Feindt J
J Neurooncol; 2007 Jan; 81(1):39-48. PubMed ID: 16850107
[TBL] [Abstract][Full Text] [Related]
29. Suppression of human breast cancer cell metastasis by coptisine in vitro.
Li J; Qiu DM; Chen SH; Cao SP; Xia XL
Asian Pac J Cancer Prev; 2014; 15(14):5747-51. PubMed ID: 25081696
[TBL] [Abstract][Full Text] [Related]
30. In vitro and in vivo MMP gene expression localisation by In Situ-RT-PCR in cell culture and paraffin embedded human breast cancer cell line xenografts.
Haupt LM; Thompson EW; Trezise AE; Irving RE; Irving MG; Griffiths LR
BMC Cancer; 2006 Jan; 6():18. PubMed ID: 16430785
[TBL] [Abstract][Full Text] [Related]
31. Inhibitory effects of resistin-13-peptide on the proliferation, adhesion, and invasion of MDA-MB-231 in human breast carcinoma cells.
Pan B; Zhao MH; Chen Z; Lu L; Wang Y; Shi DW; Han PZ
Endocr Relat Cancer; 2007 Dec; 14(4):1063-71. PubMed ID: 18045957
[TBL] [Abstract][Full Text] [Related]
32. Association of a high activity of matrix metalloproteinase-9 to low levels of tissue inhibitors of metalloproteinase-1 and -3 in human hepatitis B-viral hepatoma cells.
Kim JR; Kim CH
Int J Biochem Cell Biol; 2004 Nov; 36(11):2293-306. PubMed ID: 15313474
[TBL] [Abstract][Full Text] [Related]
33. Tenascin-C upregulates matrix metalloproteinase-9 in breast cancer cells: direct and synergistic effects with transforming growth factor beta1.
Kalembeyi I; Inada H; Nishiura R; Imanaka-Yoshida K; Sakakura T; Yoshida T
Int J Cancer; 2003 May; 105(1):53-60. PubMed ID: 12672030
[TBL] [Abstract][Full Text] [Related]
34. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
[TBL] [Abstract][Full Text] [Related]
35. The role of a new CD44st in increasing the invasion capability of the human breast cancer cell line MCF-7.
Fang XJ; Jiang H; Zhao XP; Jiang WM
BMC Cancer; 2011 Jul; 11():290. PubMed ID: 21749678
[TBL] [Abstract][Full Text] [Related]
36. Functional mimetic peptide discovery isolated by phage display interacts selectively to fibronectin domain and inhibits gelatinase.
Shoari A; Rasaee MJ; Kanavi MR; Daraei B
J Cell Biochem; 2019 Dec; 120(12):19699-19711. PubMed ID: 31270859
[TBL] [Abstract][Full Text] [Related]
37. Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in human female cancer cell lines.
Roomi MW; Kalinovsky T; Rath M; Niedzwiecki A
Oncol Rep; 2012 Sep; 28(3):768-76. PubMed ID: 22736175
[TBL] [Abstract][Full Text] [Related]
38. Vitamin D3 inhibits expression and activities of matrix metalloproteinase-2 and -9 in human uterine fibroid cells.
Halder SK; Osteen KG; Al-Hendy A
Hum Reprod; 2013 Sep; 28(9):2407-16. PubMed ID: 23814095
[TBL] [Abstract][Full Text] [Related]
39. A new gallium complex inhibits tumor cell invasion and matrix metalloproteinase MMP-14 expression and activity.
Mohsen A; Collery P; Garnotel R; Brassart B; Etique N; Mohamed Sabry G; Elsherif Hassan R; Jeannesson P; Desmaële D; Morjani H
Metallomics; 2017 Aug; 9(8):1176-1184. PubMed ID: 28765844
[TBL] [Abstract][Full Text] [Related]
40. TGF-β1 modulates the homeostasis between MMPs and MMP inhibitors through p38 MAPK and ERK1/2 in highly invasive breast cancer cells.
Gomes LR; Terra LF; Wailemann RA; Labriola L; Sogayar MC
BMC Cancer; 2012 Jan; 12():26. PubMed ID: 22260435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
